2.1 Any symptoms of stress‐related outcome (follow‐up up to 3 months after the end of the intervention) |
35 |
2366 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.55 [‐0.70, ‐0.40] |
2.1.1 No intervention |
22 |
1565 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.48 [‐0.61, ‐0.35] |
2.1.2 Wait list |
8 |
429 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.88 [‐1.53, ‐0.24] |
2.1.3 Placebo |
3 |
168 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.43 [‐0.74, ‐0.12] |
2.1.4 No stress‐reduction intervention |
2 |
204 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.27 [‐0.55, 0.00] |
2.2 Any symptoms of stress‐related outcome (follow‐up > 3 to 12 months after the end of the intervention) |
6 |
427 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.41 [‐0.79, ‐0.03] |
2.2.1 No intervention |
4 |
312 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.43 [‐0.98, 0.12] |
2.2.2 Wait list |
2 |
115 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.40 [‐0.77, ‐0.03] |
2.3 Psychological symptoms: anxiety and depression (follow‐up up to 3 months after the end of the intervention) |
7 |
378 |
Std. Mean Difference (IV, Random, 95% CI) |
‐1.07 [‐1.95, ‐0.19] |
2.3.1 No intervention |
2 |
127 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.67 [‐1.60, 0.25] |
2.3.2 Wait list |
3 |
173 |
Std. Mean Difference (IV, Random, 95% CI) |
‐1.89 [‐4.24, 0.46] |
2.3.3 Placebo |
2 |
78 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.34 [‐0.79, 0.11] |
2.4 Explanatory analysis ‐ subgroup (short vs long duration of intervention): any symptoms of stress‐related outcome (follow‐up up to 3 months after the end of the intervention) |
35 |
2366 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.55 [‐0.70, ‐0.40] |
2.4.1 Short (<12 weeks) |
33 |
2255 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.52 [‐0.68, ‐0.37] |
2.4.2 Long (≥ 12 weeks) |
2 |
111 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.96 [‐1.48, ‐0.43] |